DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study

Objectives: DEB-TACE with irinotecan and C-TACE were compared with regards to safety and efficacy for the therapy of intrahepatic cholangiocarcinoma (ICC). Methods: Institutional Review Board approved our trial and we registered it in the Chinese Clinical Trial Registry (ChiCTR1900022856). Forty pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junxiao, Xue, Yaoqin, Liu, Rui, Wen, Zhenyu, Ma, Zhenhu, Yang, Xiang, Yu, Lingxiang, Yang, Bin, Xie, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878160/
https://www.ncbi.nlm.nih.gov/pubmed/36714623
http://dx.doi.org/10.3389/fbioe.2022.1112500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878160/
https://www.ncbi.nlm.nih.gov/pubmed/36714623
http://dx.doi.org/10.3389/fbioe.2022.1112500

Ejemplares similares